Q1. How many patients have been treated (for any condition) in the last 4 months with:
a. Benralizumab
b. Omalizumab
c. Reslizumab
d. Mepolizumab
Q2. Of the patients treated in the last 4 months with any of the above products, please provide the number of patients by the following age-groups:
a. Age 6-11
b. Age 12-17
c. Age 18 and above
Q3. How many patients have been treated in the last 4 months with Dupilumab for:
a. Asthma ONLY
b. Chronic rhinosinusitis with nasal polyps ONLY
Q4. How many patients have been treated in the last 4 months with Omalizumab for:
a. Asthma ONLY
b. Chronic rhinosinusitis with nasal polyps ONLY
c. Chronic Spontaneous Urticaria ONLY

Asthma, Chronic rhinosinusitis with nasal polyps and Chronic Spontaneous Urticaria.060922.docx